StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2022 - 09 - 13
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 09
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
Sector
Health technology
11
Tags
Expected
1
Global
1
Market
1
N/a
11
Research
1
Entities
3m company
8
Abbott laboratories
37
Abbvie inc.
167
Abcam plc
7
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
9
Adc therapeutics sa
8
Agios pharmaceuticals, inc.
12
Alibaba group holding limited
7
Alico, inc.
7
Alnylam pharmaceuticals, inc.
11
Amgen inc.
744
Astellas pharma inc
31
Astrazeneca plc
106
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
19
Baxter international inc.
22
Becton, dickinson and company
9
Beigene, ltd.
117
Biocryst pharmaceuticals, inc.
13
Biogen inc.
49
Biomarin pharmaceutical inc.
8
Blueprint medicines corporation
12
Bristol-myers squibb company
86
Chemocentryx, inc.
51
Clovis oncology, inc.
10
Credit suisse group
8
Credit suisse group ag
8
Eli lilly and company
88
Entera bio ltd.
35
Epizyme, inc.
10
Exelixis, inc.
12
Genmab a/s
11
Gilead sciences, inc.
35
Glaxosmithkline plc
110
Illumina, inc.
15
Incyte corporation
12
Intel corporation
8
Johnson & johnson
94
Karyopharm therapeutics inc.
12
Medtronic plc
17
Morgan stanley
10
Norfolk southern corporation
10
Novartis ag
196
Novo nordisk a/s
17
Omeros corporation
14
Orchard therapeutics plc
8
Otonomy, inc.
14
Pfizer, inc.
34
Regeneron pharmaceuticals, inc.
27
Rigel pharmaceuticals, inc.
11
Sanofi
170
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
83
Thermo fisher scientific inc
21
Ucb s.a.
10
Verastem, inc.
10
Viatris inc.
37
Xeris pharmaceuticals, inc.
11
Y-mabs therapeutics, inc.
11
Symbols
ABBV
11
AMGN
11
ANIP
1
ARAV
1
AYTU
1
AZN
1
AZNCF
1
BCRX
10
BLUE
1
BMY
10
BSX
1
EQT
1
GILD
11
GLAXF
1
GLYC
1
GSK
1
HZNP
1
IART
2
ITRM
2
JNJ
2
KKR
1
LLY
10
MOR
1
NVS
2
OCUL
1
OMER
10
OTIC
10
PFE
10
REGN
7
SCYX
1
SNY
14
SNYNF
3
TELA
2
VNDA
1
VRNA
1
XERS
130
Exchanges
Nasdaq
11
Nyse
11
Crawled Date
2022 - 09 - 13
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
Crawled Time
00:00
4
10:51
1
12:34
1
13:17
1
13:27
1
14:03
1
15:20
1
17:43
1
Source
www.fda.gov
10
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Xeris pharmaceuticals, inc.
symbols :
Amgn
save search
Global Bio-Pharma Market is Expected to reach USD 703.28 Billion by 2027 at 12.5% CAGR, Says Brandessence Market Research
Published:
2022-09-13
(Crawled : 15:20)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
0
|
Health Technology
|
23.29%
|
O:
-4.5%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
18.22%
|
O:
1.78%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
13.83%
|
O:
-1.22%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
25.92%
|
O:
-1.39%
H:
0.31%
C:
-1.16%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
17.97%
|
O:
-1.19%
H:
0.98%
C:
-1.44%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-3.83%
|
O:
-4.92%
H:
5.17%
C:
2.87%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
14.8%
|
O:
-0.97%
H:
0.16%
C:
-0.98%
AZN
|
News
|
$75.37
5.86%
2.7M
|
Health Technology
|
15.3%
|
O:
-2.2%
H:
0.2%
C:
-2.32%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
14.89%
|
O:
-0.25%
H:
0.05%
C:
-4.29%
research
global
expected
market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-07-23
(Crawled : 00:00)
- fda.gov
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
Email alert
Add to watchlist
SCYX
|
$1.5
-3.23%
-3.68%
5
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-24
(Crawled : 14:03)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-32.73%
|
O:
0.23%
H:
0.52%
C:
0.13%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
246.48%
|
O:
8.21%
H:
1.89%
C:
-0.83%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-25.13%
|
O:
0.31%
H:
1.15%
C:
0.6%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
47.19%
|
O:
0.37%
H:
1.55%
C:
0.28%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-54.87%
|
O:
0.0%
H:
10.77%
C:
10.77%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-8.9%
|
O:
0.29%
H:
0.8%
C:
0.17%
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-80.32%
|
O:
0.32%
H:
0.87%
C:
0.26%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
0.65%
|
O:
0.18%
H:
2.2%
C:
0.61%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-75.22%
|
O:
0.06%
H:
0.35%
C:
0.0%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
14.37%
|
O:
0.71%
H:
1.09%
C:
0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-32.31%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
244.18%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-26.49%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
48.34%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-57.18%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-10.24%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-79.81%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
0.71%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-73.51%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
14.38%
|
O:
0.4%
H:
0.53%
C:
0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-09
(Crawled : 10:51)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-32.38%
|
O:
0.39%
H:
2.15%
C:
2.08%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
240.83%
|
O:
0.29%
H:
2.43%
C:
2.1%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-23.3%
|
O:
0.5%
H:
2.39%
C:
2.16%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
49.37%
|
O:
0.48%
H:
1.36%
C:
0.99%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-54.87%
|
O:
7.18%
H:
4.52%
C:
-4.07%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-8.86%
|
O:
0.88%
H:
0.74%
C:
0.5%
OTIC
|
$0.077
|
Health Technology
|
-96.75%
|
O:
-0.84%
H:
5.93%
C:
0.42%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-80.82%
|
O:
0.95%
H:
2.0%
C:
0.25%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
-0.64%
|
O:
0.09%
H:
2.4%
C:
1.6%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-75.29%
|
O:
0.82%
H:
2.39%
C:
-1.11%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
15.28%
|
O:
0.46%
H:
1.42%
C:
0.67%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-24
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-34.24%
|
O:
0.33%
H:
0.15%
C:
-0.67%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
276.33%
|
O:
0.56%
H:
1.3%
C:
0.01%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-27.13%
|
O:
0.33%
H:
1.03%
C:
0.03%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
44.51%
|
O:
0.4%
H:
0.19%
C:
-0.58%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-49.28%
|
O:
-1.15%
H:
1.46%
C:
-4.66%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-11.85%
|
O:
0.02%
H:
0.3%
C:
-0.3%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
78.9%
|
O:
0.6%
H:
0.0%
C:
-1.82%
OTIC
|
$0.077
|
Health Technology
|
-96.87%
|
O:
1.21%
H:
0.0%
C:
-7.2%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-79.58%
|
O:
0.94%
H:
1.4%
C:
1.06%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
-2.43%
|
O:
0.51%
H:
0.2%
C:
-2.42%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-69.62%
|
O:
0.43%
H:
1.44%
C:
-2.16%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
8.76%
|
O:
-0.18%
H:
1.17%
C:
-1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-18
(Crawled : 13:27)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-34.51%
|
O:
0.17%
H:
0.41%
C:
-0.32%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
284.7%
|
O:
-0.27%
H:
0.69%
C:
-0.19%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-25.36%
|
O:
-0.06%
H:
0.58%
C:
0.28%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
43.55%
|
O:
-0.67%
H:
1.54%
C:
0.95%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-49.43%
|
O:
0.0%
H:
5.46%
C:
3.16%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-11.3%
|
O:
0.22%
H:
0.1%
C:
-0.26%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
73.09%
|
O:
-0.14%
H:
0.0%
C:
-1.3%
OTIC
|
$0.077
|
Health Technology
|
-96.73%
|
O:
-0.84%
H:
4.63%
C:
1.7%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-82.91%
|
O:
0.06%
H:
1.35%
C:
-0.06%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
-2.88%
|
O:
0.49%
H:
0.66%
C:
-0.81%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-70.72%
|
O:
-0.76%
H:
4.91%
C:
0.77%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
8.17%
|
O:
-0.12%
H:
0.4%
C:
-0.48%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-12
(Crawled : 17:43)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-33.24%
|
O:
0.23%
H:
1.22%
C:
0.63%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
286.24%
|
O:
0.0%
H:
0.46%
C:
-0.8%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-23.97%
|
O:
0.26%
H:
1.24%
C:
0.16%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
46.05%
|
O:
-0.03%
H:
1.0%
C:
0.1%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-48.54%
|
O:
-2.68%
H:
7.56%
C:
0.05%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-8.67%
|
O:
-0.46%
H:
0.95%
C:
0.12%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
80.88%
|
O:
-0.84%
H:
3.35%
C:
2.04%
OTIC
|
$0.077
|
Health Technology
|
-96.28%
|
O:
1.92%
H:
4.25%
C:
1.42%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-83.51%
|
O:
-1.41%
H:
2.86%
C:
-1.76%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
-0.21%
|
O:
-0.7%
H:
1.8%
C:
1.05%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-65.32%
|
O:
-1.98%
H:
6.47%
C:
4.96%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
8.21%
|
O:
-0.35%
H:
0.92%
C:
-0.23%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-22
(Crawled : 12:34)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-33.54%
|
O:
-0.13%
H:
0.05%
C:
-2.13%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
293.93%
|
O:
-0.5%
H:
0.67%
C:
-1.55%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-26.33%
|
O:
-0.26%
H:
0.62%
C:
0.26%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
51.44%
|
O:
-0.14%
H:
0.4%
C:
-0.54%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-54.64%
|
O:
0.26%
H:
4.37%
C:
-0.26%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-9.56%
|
O:
-0.93%
H:
0.27%
C:
0.17%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
78.99%
|
O:
-0.21%
H:
0.0%
C:
-2.96%
OTIC
|
$0.077
|
Health Technology
|
-96.61%
|
O:
0.0%
H:
3.51%
C:
0.88%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-84.11%
|
O:
0.1%
H:
0.31%
C:
-3.03%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
0.43%
|
O:
-0.46%
H:
0.05%
C:
-1.26%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-63.89%
|
O:
-0.34%
H:
8.09%
C:
3.7%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
5.5%
|
O:
-0.48%
H:
0.36%
C:
-0.97%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-20
(Crawled : 13:17)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-32.52%
|
O:
-0.46%
H:
1.26%
C:
0.72%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
296.65%
|
O:
0.41%
H:
1.62%
C:
0.11%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-25.52%
|
O:
-0.23%
H:
1.65%
C:
0.96%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
54.5%
|
O:
-0.45%
H:
1.33%
C:
0.84%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-52.82%
|
O:
-0.8%
H:
3.24%
C:
2.97%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-8.44%
|
O:
-0.08%
H:
0.42%
C:
0.42%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
81.42%
|
O:
-0.03%
H:
1.44%
C:
0.97%
OTIC
|
$0.077
|
Health Technology
|
-96.68%
|
O:
0.0%
H:
0.86%
C:
-1.72%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-83.19%
|
O:
-0.83%
H:
4.52%
C:
3.46%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
1.71%
|
O:
-0.23%
H:
1.22%
C:
0.88%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-63.42%
|
O:
-0.17%
H:
3.22%
C:
-3.31%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
6.66%
|
O:
-0.44%
H:
2.17%
C:
1.69%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-12
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.38%
130K
|
Health Technology
|
-28.22%
|
O:
-0.33%
H:
1.52%
C:
1.34%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
307.72%
|
O:
-0.57%
H:
0.28%
C:
-0.88%
BMY
|
$46.72
-4.38%
2M
|
Health Technology
|
-21.96%
|
O:
-0.13%
H:
0.39%
C:
0.26%
ABBV
|
News
|
$168.67
0.52%
260K
|
Health Technology
|
56.03%
|
O:
0.26%
H:
0.7%
C:
0.4%
XERS
|
$1.74
-1.14%
44K
|
Health Technology
|
-58.39%
|
O:
-0.47%
H:
0.12%
C:
-6.65%
SNY
|
News
|
$46.61
-2.27%
-2.21%
220K
|
Health Technology
|
-6.55%
|
O:
-0.33%
H:
0.12%
C:
-0.69%
REGN
|
News
|
$906.54
-0.09%
-0.08%
62
|
Health Technology
|
90.78%
|
O:
1.39%
H:
0.0%
C:
-1.86%
OTIC
|
$0.077
|
Health Technology
|
-96.53%
|
O:
0.0%
H:
0.9%
C:
-0.45%
OMER
|
$3.04
-1.62%
-1.64%
0
|
Health Technology
|
-83.32%
|
O:
0.0%
H:
0.0%
C:
-7.13%
GILD
|
$66.69
-0.58%
850K
|
Health Technology
|
3.03%
|
O:
-0.08%
H:
0.08%
C:
-0.61%
BCRX
|
News
|
$4.045
-3.92%
220K
|
Health Technology
|
-58.77%
|
O:
-0.59%
H:
0.1%
C:
-6.4%
AMGN
|
News
|
$271.635
-0.5%
120K
|
Health Technology
|
9.66%
|
O:
-0.17%
H:
0.6%
C:
0.17%
Gainers vs Losers
50%
50%
Top 10 Gainers
CSSE
4
|
$0.299
96.32%
7M
|
Consumer Services
BRFH
4
|
$1.99
80.91%
13M
|
Manufacturing
BOF
|
$1.915
63.68%
620K
|
AMST
|
$3.13
56.5%
500K
|
Technology Services
ACON
|
$0.3595
24.83%
3.5M
|
n/a
CDTX
|
News
|
$14.57
18.55%
330K
|
Health Technology
ULBI
M
|
$10.12
15.92%
120K
|
Producer Manufacturing
LRHC
|
$1.79
11.88%
3K
|
n/a
AIXI
|
$1.34
8.94%
42K
|
n/a
TRU
|
$74.475
8.44%
100K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.